Medicine
Clindamycin 10 mg/mL topical solution
Clindamycin 10 mg/mL topical solution is a generic prescription medicine for topical use, made by 12 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Protect from freezing. Store at 20°C to 25°C (68°F to 77°F).
Key facts
- Active ingredient (INN)
- Clindamycin
- Brand
- Sold under the generic name
- Strength
- 10 mg/mL
- Dosage form
- Topical solution
- Route
- Topical
- Packs
- 1 bottle, 60 applicators, 30 mL and 27 more
- Manufacturers
- Sun Pharmaceutical IndustriesIndiaViona PharmaceuticalsIndiaZydus LifesciencesIndiaBryant Ranch PrepackPadagis Israel PharmaceuticalsA-S Medication SolutionsCarnegie PharmaceuticalsChartwell RXE. FougeraRising Pharma Holdings
- Origin register
- US FDA, United States
- Storage
- Protect from freezing. Store at 20°C to 25°C (68°F to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- D10AF01 Clindamycin
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 5 June 1997
- Identifiers
- RxCUI 309333, 197519, 2676585DailyMed set ID 585e8b72-b350-451f-a232-199b1a01e8ce, cc8262fe-8e41-49b2-97ae-7985e9a894e9, 62a2019f-7410-4251-95ed-181925ade6e4 +16NDC 72578-084, 16571-256, 0168-0201 +16Application ANDA208767, ANDA218300, ANDA064159 +6
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle, with applicator in 1 carton / 30 mL in 1 bottle, with applicator | 51672-4081-3 | Sun Pharmaceutical IndustriesIndia | 31 March 2004 |
| 1 bottle, with applicator in 1 carton / 60 mL in 1 bottle, with applicator | 51672-4081-4 | Sun Pharmaceutical IndustriesIndia | 31 March 2004 |
| 1 bottle, with applicator in 1 carton / 30 mL in 1 bottle, with applicator | 72578-084-02 | Viona PharmaceuticalsIndia | 15 June 2020 |
| 1 bottle, with applicator in 1 carton / 60 mL in 1 bottle, with applicator | 72578-084-03 | Viona PharmaceuticalsIndia | 15 June 2020 |
| 1 bottle in 1 carton / 30 mL in 1 bottle | 70771-1414-2 | Zydus LifesciencesIndia | 3 January 2019 |
| 1 bottle in 1 carton / 60 mL in 1 bottle | 70771-1414-3 | Zydus LifesciencesIndia | 3 January 2019 |
| 60 applicator in 1 jar / 1 mL in 1 applicator | 45802-263-37 | Padagis Israel Pharmaceuticals | 31 May 2006 |
| 1 bottle, with applicator in 1 carton / 30 mL in 1 bottle, with applicator | 45802-562-01 | Padagis Israel Pharmaceuticals | 17 September 2013 |
| 1 bottle, with applicator in 1 carton / 60 mL in 1 bottle, with applicator | 45802-562-02 | Padagis Israel Pharmaceuticals | 17 September 2013 |
| 30 mL in 1 bottle, with applicator | 45802-562-30 | Padagis Israel Pharmaceuticals | 28 April 2026 |
| 60 mL in 1 bottle, with applicator | 45802-562-60 | Padagis Israel Pharmaceuticals | 28 April 2026 |
| 60 applicator in 1 jar / 1 mL in 1 applicator | 80005-131-09 | Carnegie Pharmaceuticals | 16 June 2025 |
| 69 applicator in 1 jar / 1 mL in 1 applicator | 80005-131-38 | Carnegie Pharmaceuticals | 15 December 2025 |
| 30 mL in 1 bottle, with applicator | 62135-478-30 | Chartwell RX | 28 August 2025 |
| 60 mL in 1 bottle, with applicator | 62135-478-60 | Chartwell RX | 28 August 2025 |
| 1 bottle in 1 carton / 30 mL in 1 bottle | 0168-0201-30 | E. Fougera | 5 June 1997 |
| 1 bottle in 1 carton / 60 mL in 1 bottle | 0168-0201-60 | E. Fougera | 5 June 1997 |
| 60 applicator in 1 jar / 1 mL in 1 applicator | 72319-696-60 | i3 Pharmaceuticals | 16 June 2025 |
| 60 applicator in 1 jar / 1 mL in 1 applicator | 16571-256-60 | Rising Pharma Holdings | 23 March 2026 |
| 69 applicator in 1 jar / 1 mL in 1 applicator | 16571-256-69 | Rising Pharma Holdings | 23 March 2026 |
| 1 bottle, with applicator in 1 carton / 30 mL in 1 bottle, with applicator | 63629-8633-1 | Bryant Ranch Prepack | 17 September 2013 |
| 1 bottle, with applicator in 1 carton / 60 mL in 1 bottle, with applicator | 63629-8634-1 | Bryant Ranch Prepack | 17 September 2013 |
| 1 bottle, with applicator in 1 carton / 30 mL in 1 bottle, with applicator | 71335-2861-1 | Bryant Ranch Prepack | 24 October 2025 |
| 1 bottle, with applicator in 1 carton / 60 mL in 1 bottle, with applicator | 71335-2863-1 | Bryant Ranch Prepack | 24 October 2025 |
| 1 bottle, with applicator in 1 carton / 30 mL in 1 bottle, with applicator | 72162-1418-3 | Bryant Ranch Prepack | 17 September 2013 |
| 1 bottle, with applicator in 1 carton / 60 mL in 1 bottle, with applicator | 72162-1418-6 | Bryant Ranch Prepack | 17 September 2013 |
| 60 applicator in 1 jar / 1 mL in 1 applicator | 50090-1932-0 | A-S Medication Solutions | 16 July 2015 |
| 1 bottle, with applicator in 1 carton / 60 mL in 1 bottle, with applicator | 50090-2611-0 | A-S Medication Solutions | 10 November 2016 |
| 1 bottle, with applicator in 1 carton / 60 mL in 1 bottle, with applicator | 50090-6593-0 | A-S Medication Solutions | 17 August 2023 |
| 1 bottle, with applicator in 1 carton / 60 mL in 1 bottle, with applicator | 68788-7990-6 | Preferred Pharmaceuticals | 6 August 2021 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 22 February 1970 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Clindamycin 10 mg/mL topical solution.
- Clindamycin Phoaphate Topical Solution USP, 1% 10 mg/mL topical solutionAvailable on requestEncube EthicalsUS FDA4 packs
- Clindacin P 10 mg/mL topical solutionAvailable on requestEurofarmaUS FDA2 packs
- Clindamycin Phoaphate Topical USP, 1% 10 mg/mL topical solutionAvailable on requestA-S Medication SolutionsUS FDA1 pack
Other strengths and forms of Clindamycin
Clinical summary
Clindamycin is a lincosamide antibacterial indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. It is available as capsules, injection and gel for oral, topical and intravenous use. MedsAcross supplies Clindamycin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about ClindamycinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Cleocin Hydrochloride prescribing information (Pharmacia & Upjohn) · U.S. National Library of Medicine, DailyMed
Need Clindamycin 10 mg/mL topical solution for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.